FUNDACIÓN FAD JUVENTUD
Fad Juventud
Fundacion Fad Juventud (Fad Juventud) purpose is to improve the welfare and quality of life of young people.
ID: 117281631177-13
Lobbying Activity
Response to Revision of the mandate of the European Monitoring Centre for Drugs and Drug Addiction
6 Apr 2022
As a member of the CSFD, Fundación Fad Juventud welcomes a renewed mandate for the EMCDDA, as it plays a critical role in collecting and analysing reliable data and in facilitating the development and implementation of evidence-based drug policies across the EU. A stronger, well-funded agency is therefore to be applauded. The CSFD also wishes to highlight the following positive areas of work included in the EC proposal:
• The CSFD welcomes the enhanced role the EMCDDA would have in monitoring national drug policies, as well as its ability to evaluate and accredit national drug programmes. The EMCDDA plays a major role in collecting data and conducting objective analysis on the effectiveness of drug policies and programmes. This enhanced role will therefore facilitate the adoption and adaptation of national drug policies and programmes based on solid scientific evidence across the EU.
• The proposal provides for the EMCDDA to review and certify the national focal points that comprise the Reitox network. This is also a positive step in ensuring that the data provided by the focal points is reliable.
• The CSFD welcomes the fact that EMCDDA will play a stronger role in monitoring, assessing and collecting data on supply reduction policies and programmes. Indeed, in the past, there has been little scrutiny on whether supply reduction efforts are indeed evidence- and human rights-based. This is an opportunity for the EMCDDA to develop new indicators to evaluate supply reduction policies grounded in evidence and human rights.
• Finally, the new mandate would enable the EMCDDA to engage more intensively in international data monitoring and cooperation, including by supporting the HDG and the Commission on their international work, providing information to the UN Office on Drugs and Crime and the World Health Organization (WHO) and in providing support to third countries. There has been much criticism on the quality and level of data collection at the UN with regards to drugs and drug policy. The EMCDDA has a critical role to play in both sharing data and analysis from EU member states, and in building the capacity of other agencies at national, regional and global level to monitor drug policies and programmes.
Read full response